CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) (NCT07220304)
CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates the use of CaRi-Heart® analysis, an artificial-intelligence (AI) software tool that measures inflammation in the coronary arteries using images already captured during a standard Coronary CT Angiography (CCTA) exam. The goal is to determine whether the additional information provided by CaRi-Heart® changes clinical decision-making and helps improve early identification and management of coronary artery disease in community imaging centers. Patients who undergo CCTA as part of their regular care will be invited to have their scans analyzed using CaRi-Heart® at no extra cost, time, or radiation.
Who can join: Review the eligibility criteria below.
Location: Corazon Imaging — Bay City, Michigan
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Corazon Imaging — Bay City, Michigan
- Corazon Imaging — Berkley, Michigan
- Corazon Imaging — Caro, Michigan
- Corazon Imaging — Dearborn, Michigan
- Corazon Imaging — Flint, Michigan
- Corazon Imaging — Grand Rapids, Michigan
- Corazon Imaging — Livonia, Michigan
- Corazon Imaging — Macomb, Michigan
- Corazon Imaging — Madison Heights, Michigan
- Corazon Imaging — Mount Pleasant, Michigan
- Corazon Imaging — Novi, Michigan
- Corazon Imaging — Saginaw, Michigan
- Corazon Imaging — Saint Clair Shores, Michigan
- Corazon Imaging — Sterling Heights, Michigan
- Corazon Imaging — Trenton, Michigan
- Corazon Imaging — Waterford, Michigan
- Corazon Imaging — Elizabethtown, Pennsylvania
- Corazon Imaging — Lemoyne, Pennsylvania
📞 Contact the Study Coordinator
Phone: (313) 658-7778
Email: habdallah@corazonimaging.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Artery Disease
- Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended — Stanford, California
- Genomic Investigation of Cardiovascular Diseases — La Jolla, California
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health — Boston, Massachusetts
- A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD — Mobile, Alabama
- Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Birmingham, Alabama
- Precision PCI Registry — Gainesville, Florida
Explore by condition: All Coronary Artery Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.